- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2010
- Public Summary Document (PSD) March 2010 PBAC Meeting - PDF
Rituximab – March 2010
Rituximab, solution for IV infusion, 100 mg in 10 mL and 500 mg in 50 mL, MabThera®- March 2010
Last updated
2 July 2010